[1] BENJAMIN E J,VIRANI S S,CALLAWAY C W,et al. Heart Disease and Stroke Statistics-2018 Update:a report from the American Heart Association[J].Circulation,2018,137(12):e67-e492.
[2] VIRANI S S,ALONSO A,BENJAMIN E J,et al. Heart Disease and Stroke Statistics-2020 Update:a report from the American Heart Association [J].Circulation,2020,141(9):e139-e596.
[3] ALBERTI K G,ECKEL R H,GRUNDY S M,et al. Harmonizing the metabolic syndrome:a joint interim statement of the international diabetes federation task force on epidemiology and prevention;National Heart,Lung,and Blood Institute;American Heart Association;world heart federation;international atherosclerosis society;and International Association for the Study of obesity[J].Circulation,2009,120(16):1640–1645.
[4] LACLAUSTRA M,ORDONEZ B,LEON M,et al. Metabolic syndrome and coronary heart disease among Spanish male workers:a case-control study of MESYAS[J]. Nutr Metab Cardiovasc Dis,2012,22(6):510-516.
[5] GUO J,ZHOU T,TAO L,et al. Correlation between components and different combinations of metabolic syndrome and coronary heart disease[J]. Chin J Public Health,2016,32(5):632-636.
[7] 诸骏仁,高润霖,赵水平,等. 中国成人血脂异常防治指南(2016年修订版) [J].中国循环杂志,2016,31(10):937-953.
[8] LIU Z,WEI R,LI Y. Coronary heart disease is associated with nonalcoholic fatty liver disease in patients without hypertension and diabetes [J]. Medicine,2020,99(26):e20898.
[9] LI C J,HE J,WEI B,et al. Effect of metabolic syndrome on coronary heart disease in rural minorities of Xinjiang:a retrospective cohort study[J].BMC Public Health,2020,20(1):553.
[10] DAI Y,WAN X,LI X,et al. Neck circumference and future cardiovascular events in a high-risk population--a prospective cohort study [J]. Lipids Health Dis,2016,15:46.
[11] ETTO C E,WINEKE B,VICTOR WMVH. Paracrine regulation of vascular tone,inflammation and insulin sensitivity by perivascular adipose tissue[J]. Vascul Pharmacol,2012,56 (5/6):204-209.
[12] MORRISON A,HOKANSON J E. The independent relationship between triglycerides and coronary heart disease[J]. Vasc Health Risk Manag,2009,5(1):89-95.
[13] CHEN Q,ZHANG Y,DING D,et al. Metabolic syndrome and its individual components with mortality among patients with coronary heart disease[J]. Int J Cardiol,2016,224:8-14.
[14] RANA J S,ARSENAULT B J,DESPRES J P,et al. Inflammatory biomarkers,physical activity,waist circumference,and risk of future coronary heart disease in healthy men and women[J]. Eur Heart J,2011,32(3):336-344.
[15] MEDINA-INOJOSA J R,BATSIS J A,SUPERVIA M,et al. Relation of waist-hip ratio to long-term cardiovascular events in patients with coronary artery disease[J]. Am J Cardiol,2018,121(8):903-909.
[16] ZHOU J Y,GE H,ZHU M F,et al. Neck circumference as an independent predictive contributor to cardio-metabolic syndrome[J]. Cardiovasc Diabetol,2013,12:76.
[17] LIANG J,WANG Y,LI H,et al. Neck circumference and early stage atherosclerosis:the cardiometabolic risk in Chinese(CRC) study[J]. Cardiovas Diabetol,2014,13:107.
[1]陈 云,袁如玉,阎哲慧,等.动态动脉硬化指数对原发性高血压患者冠心病的预测价值[J].天津医科大学学报,2013,19(06):468.
CHEN Yun,YUAN Ru-yu,YAN Zhe-hui,et al.Predictive value of ambulatory arterial stiffness index for coronary heart disease in primary hypertensive patients[J].Journal of Tianjin Medical University,2013,19(01):468.
[2]蒋森森,周长钰.平均血小板体积、红细胞分布宽度与冠心病的相关性研究[J].天津医科大学学报,2014,20(02):120.
JIANG Sen-sen,ZHOU Chang-yu.Correlation between mean platelet volume, red blood cell distribution width and coronary heart disease [J].Journal of Tianjin Medical University,2014,20(01):120.
[3]巩江华,周长钰.RT-3DE在评价冠状动脉病变中的价值[J].天津医科大学学报,2014,20(02):131.
GONG Jiang-hua,ZHOU Chang-yu.Evaluation of coronary artery stenosis by using real-time three-dimensional echocardiography[J].Journal of Tianjin Medical University,2014,20(01):131.
[4]彭云玲,齐 新,魏丽萍,等.冠心病心力衰竭患者心率变异性分析[J].天津医科大学学报,2014,20(05):363.
PENG Yun-ling,QI Xin,WEI Li-ping,et al.Analysis on heart rate variability in heart failure patients with coronary heart disease[J].Journal of Tianjin Medical University,2014,20(01):363.
[5]谭艳萍,吴校伟,刘 寅,等. 冠心病合并糖尿病患者药物涂层支架术后观察[J].天津医科大学学报,2014,20(05):414.
[6]李佳丽,姚朱华,马 梅,等.冠心病合并阻塞性睡眠呼吸暂停低通气综合征临床分析[J].天津医科大学学报,2014,20(06):472.
[7]刘洪梅综述,李广平审校. 血清胆红素在冠心病患者中的应用价值研究进展[J].天津医科大学学报,2014,20(06):506.
[8]刘 瑞,刘玉洁,何 乐.CETP TaqIB基因多态性与血脂及冠心病相关性研究[J].天津医科大学学报,2015,21(02):117.
LIU Rui,LIU Yu-jie,HE Le.Studies on the correlation between CETP TaqIB gene polymorphism and blood lipid and coronary heart disease[J].Journal of Tianjin Medical University,2015,21(01):117.
[9]李文军,刘相丽,孙丽丽,等.血清胱抑素C在急性冠脉综合征中的预测价值[J].天津医科大学学报,2015,21(03):189.
LI Wen-jun,LIU Xiang-li,SUN Li-li,et al.Prediction value of plasma cystatin C level in patients with acute coronary syndrome[J].Journal of Tianjin Medical University,2015,21(01):189.
[10]刘先锋,张 晶,丛洪良.血浆同型半胱氨酸水平与传统冠心病危险因素关系及对冠心病进展的作用[J].天津医科大学学报,2016,22(04):343.